US FDA seeks input on boosting device R&D for pediatric rare diseases
This article was originally published in Clinica
Executive Summary
The US FDA is to hold a public workshop next year to elicit feedback on how the agency can encourage and accelerate the development of medical devices for treating rare diseases in pediatric patients.